FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046490713> ?p ?o ?g. }

• W2046490713 endingPage "300" @default.
• W2046490713 startingPage "281" @default.
• W2046490713 abstract "(±)-7β,8α-Dihydroxy-9β,10β-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (diol epoxide-1) and (±)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (diol epoxide-2) are highly mutagenic diol epoxide diastereomers that are formed during metabolism of the carcinogen (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene. Remarkable stereoselectivity has been observed on metabolism of the optically pure (+)- and (−)-enantiomers of the dihydrodiol which are obtained by separation of the diastereomeric diesters with (−)-α-methoxy-α-trifluoromethylphenylacetic acid. The high stereoselectivity in the formation of diol epoxide-1 relative to diol epoxide-2 was observed with liver microsomes from 3-methylcholanthrene-treated rats and with a purified cytochrome P-448-containing monoxygenase system where the (−)-enantiomer produced a diol epoxide-2 to diol epoxide-1 ratio of 6 : 1 and the (+)-enantiomer produced a ratio of 1 : 22. Microsomes from control and phenobarbital-treated rats were less stereospecific in the metabolism of enantiomers of BP 7,8-dihydrodiol. The ratio of diol epoxide-2 to diol epoxide-1 formed from the (−)- and (+)-enantiomers with microsomes from control rats was 2 : 1 and 1 : 6, respectively. Both enantiomers of BP 7,8-dihydrodiol were also metabolized to a phenolic derivative, tentatively identified as 6,7,8-trihydroxy-7,8-dihydrobenzo[a]pyrene, which accounted for ∼30% of the total metabolites formed by microsomes from control and phenobarbital-pretreated rats whereas this metabolite represents ∼5% of the total metabolites with microsomes from 3-methylcholanthrene-treated rats. With benzo[a]pyrene as substrate, liver microsomes produced the 4,5-, 7,8- and 9,10-dihydrodiol with high optical purity (>85%), and diol epoxides were also formed. Most of the optical activity in the BP 7,8-dihydrodiol was due to metabolism by the monoxygenase system rather than by epoxide hydrase, since hydration of (±)-benzo[a]pyrene 7,8-oxide by liver microsomes produced dihydrodiol which was only 8% optically pure. Thus, the stereospecificity of both the monoxygenase system and, to a lesser extent, epoxide hydrase plays important roles in the metabolic activation of benzo[a]pyrene to carcinogens and mutagens." @default.
• W2046490713 created "2016-06-24" @default.
• W2046490713 creator A5009400900 @default.
• W2046490713 creator A5010768963 @default.
• W2046490713 creator A5023584195 @default.
• W2046490713 creator A5026253950 @default.
• W2046490713 creator A5037441645 @default.
• W2046490713 creator A5041036987 @default.
• W2046490713 creator A5041039348 @default.
• W2046490713 creator A5045174225 @default.
• W2046490713 creator A5070038519 @default.
• W2046490713 date "1977-03-01" @default.
• W2046490713 modified "2023-10-12" @default.
• W2046490713 title "Metabolism of benzo[a]pyrene VI. Stereoselective metabolism of benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol to diol epoxides" @default.
• W2046490713 cites W1494928814 @default.
• W2046490713 cites W1602211564 @default.
• W2046490713 cites W1606055716 @default.
• W2046490713 cites W172739833 @default.
• W2046490713 cites W1974648730 @default.
• W2046490713 cites W1984713897 @default.
• W2046490713 cites W1996686892 @default.
• W2046490713 cites W1998461385 @default.
• W2046490713 cites W2006253201 @default.
• W2046490713 cites W2021022873 @default.
• W2046490713 cites W2022806505 @default.
• W2046490713 cites W2043966259 @default.
• W2046490713 cites W2049714709 @default.
• W2046490713 cites W2056995321 @default.
• W2046490713 cites W2061001369 @default.
• W2046490713 cites W2066257734 @default.
• W2046490713 cites W2072389657 @default.
• W2046490713 cites W2088800163 @default.
• W2046490713 cites W3005276651 @default.
• W2046490713 cites W3005341051 @default.
• W2046490713 cites W4240072170 @default.
• W2046490713 doi "https://doi.org/10.1016/0009-2797(77)90108-9" @default.
• W2046490713 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/862130" @default.
• W2046490713 hasPublicationYear "1977" @default.
• W2046490713 type Work @default.
• W2046490713 sameAs 2046490713 @default.
• W2046490713 citedByCount "255" @default.
• W2046490713 countsByYear W20464907132012 @default.
• W2046490713 countsByYear W20464907132013 @default.
• W2046490713 countsByYear W20464907132014 @default.
• W2046490713 countsByYear W20464907132015 @default.
• W2046490713 countsByYear W20464907132016 @default.
• W2046490713 countsByYear W20464907132017 @default.
• W2046490713 countsByYear W20464907132020 @default.
• W2046490713 countsByYear W20464907132021 @default.
• W2046490713 countsByYear W20464907132022 @default.
• W2046490713 crossrefType "journal-article" @default.
• W2046490713 hasAuthorship W2046490713A5009400900 @default.
• W2046490713 hasAuthorship W2046490713A5010768963 @default.
• W2046490713 hasAuthorship W2046490713A5023584195 @default.
• W2046490713 hasAuthorship W2046490713A5026253950 @default.
• W2046490713 hasAuthorship W2046490713A5037441645 @default.
• W2046490713 hasAuthorship W2046490713A5041036987 @default.
• W2046490713 hasAuthorship W2046490713A5041039348 @default.
• W2046490713 hasAuthorship W2046490713A5045174225 @default.
• W2046490713 hasAuthorship W2046490713A5070038519 @default.
• W2046490713 hasConcept C114246631 @default.
• W2046490713 hasConcept C138716334 @default.
• W2046490713 hasConcept C161790260 @default.
• W2046490713 hasConcept C178790620 @default.
• W2046490713 hasConcept C181199279 @default.
• W2046490713 hasConcept C181647583 @default.
• W2046490713 hasConcept C185592680 @default.
• W2046490713 hasConcept C187921627 @default.
• W2046490713 hasConcept C2776920199 @default.
• W2046490713 hasConcept C2777477808 @default.
• W2046490713 hasConcept C2777538855 @default.
• W2046490713 hasConcept C2778951431 @default.
• W2046490713 hasConcept C2779515768 @default.
• W2046490713 hasConcept C486523 @default.
• W2046490713 hasConcept C55493867 @default.
• W2046490713 hasConcept C62231903 @default.
• W2046490713 hasConcept C71240020 @default.
• W2046490713 hasConcept C87644729 @default.
• W2046490713 hasConceptScore W2046490713C114246631 @default.
• W2046490713 hasConceptScore W2046490713C138716334 @default.
• W2046490713 hasConceptScore W2046490713C161790260 @default.
• W2046490713 hasConceptScore W2046490713C178790620 @default.
• W2046490713 hasConceptScore W2046490713C181199279 @default.
• W2046490713 hasConceptScore W2046490713C181647583 @default.
• W2046490713 hasConceptScore W2046490713C185592680 @default.
• W2046490713 hasConceptScore W2046490713C187921627 @default.
• W2046490713 hasConceptScore W2046490713C2776920199 @default.
• W2046490713 hasConceptScore W2046490713C2777477808 @default.
• W2046490713 hasConceptScore W2046490713C2777538855 @default.
• W2046490713 hasConceptScore W2046490713C2778951431 @default.
• W2046490713 hasConceptScore W2046490713C2779515768 @default.
• W2046490713 hasConceptScore W2046490713C486523 @default.
• W2046490713 hasConceptScore W2046490713C55493867 @default.
• W2046490713 hasConceptScore W2046490713C62231903 @default.
• W2046490713 hasConceptScore W2046490713C71240020 @default.
• W2046490713 hasConceptScore W2046490713C87644729 @default.
• W2046490713 hasIssue "3" @default.
• W2046490713 hasLocation W20464907131 @default.

• next